Arrow Generiques opposition analysis

COMPANY ANALYSIS

Latest oppositions filed by Arrow Generiques

Patent Number:
Title:
Rapid Dissolution Formulation Of A Calcium Receptor-Active Compound
Applicant:
Opposition Date:
Aug 29, 2023
Patent Number:
Title:
Rapamycin Derivative For Treating Pancreas Cancer
Applicant:
Opposition Date:
Jun 1, 2020
Patent Number:
Title:
Rapamycin Derivative For The Treatment Of A Solid Tumor Associated With Deregulated Angiogenesis
Applicant:
Opposition Date:
Feb 24, 2020

Want to track Arrow Generiques?

Feel free to send us a message here and we will get back to you